Prevalence of hepatitis C serum antibody in autoimmune diseases

Nancy Agmon-Levin, Maya Ram, Ori Barzilai, Bat sheva Porat-Katz, Ronit Parikman, Carlo Selmi, M. Eric Gershwin, Juan Manuel Anaya, Pierre Youinou, Nicola Bizzaro, Angela Tincani, Athanasios G. Tzioufas, Ricard Cervera, Ljudmila Stojanovich, Javier Martin, Miguel Angel Gonzalez-Gay, Gabriele Valentini, Miri Blank, Marielle SanMarco, Blaž RozmanStefano Bombardieri, Salvatore De Vita, Yehuda Shoenfeld

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from the same countries and with similar age and sex distribution. All sera were tested for the presence of serum anti-hepatitis C virus (HCV) antibodies as well as antibodies directed at other infectious agents and autoantibodies. Results: Anti-HCV antibody was detected in 115/1322 (8.7%) of patients with AID and 0.4% of matched healthy controls (P < 0.0001). The prevalence of anti-HCV antibody was significantly higher in 7/18 different AID (i.e. cryoglobulinemia, mixed cryoglobulinemia pemphigus vulgaris, vasculitis, secondary anti-phospholipid syndrome, Hashimoto's thyroiditis, and inflammatory bowel disease) compared to controls. Patients with AID and serum anti-HCV positivity had an increased prevalence of antibodies against hepatitis B virus, Toxoplasma gondii and Cytomegalovirus as opposed to a lower frequency of serum autoantibodies. Conclusions: The enhanced prevalence of anti-HCV serum antibodies in AID may suggest a role for HCV in tolerance to breakdown, similarly to its established role in mixed cryoglobulinemia. This immune mediated effect does not rule out the role of other infectious agents.

Original languageEnglish (US)
Pages (from-to)261-266
Number of pages6
JournalJournal of Autoimmunity
Volume32
Issue number3-4
DOIs
StatePublished - May 2009

Fingerprint

Hepatitis C Antibodies
Autoimmune Diseases
Serum
Cryoglobulinemia
Hepacivirus
Autoantibodies
Hepatitis B Antibodies
Hashimoto Disease
Sex Distribution
Pemphigus
Antiphospholipid Syndrome
Age Distribution
Toxoplasma
Vasculitis
Cytomegalovirus
Inflammatory Bowel Diseases
Antibodies

Keywords

  • Antiphospholipids syndrome
  • Autoantibodies
  • Autoimmune diseases
  • Cryoglobulinemia
  • Hepatitis-C
  • Inflammatory bowel diseases
  • Pemphigus vulgaris
  • Thyroid autoimmune diseases

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Agmon-Levin, N., Ram, M., Barzilai, O., Porat-Katz, B. S., Parikman, R., Selmi, C., ... Shoenfeld, Y. (2009). Prevalence of hepatitis C serum antibody in autoimmune diseases. Journal of Autoimmunity, 32(3-4), 261-266. https://doi.org/10.1016/j.jaut.2009.02.017

Prevalence of hepatitis C serum antibody in autoimmune diseases. / Agmon-Levin, Nancy; Ram, Maya; Barzilai, Ori; Porat-Katz, Bat sheva; Parikman, Ronit; Selmi, Carlo; Gershwin, M. Eric; Anaya, Juan Manuel; Youinou, Pierre; Bizzaro, Nicola; Tincani, Angela; Tzioufas, Athanasios G.; Cervera, Ricard; Stojanovich, Ljudmila; Martin, Javier; Gonzalez-Gay, Miguel Angel; Valentini, Gabriele; Blank, Miri; SanMarco, Marielle; Rozman, Blaž; Bombardieri, Stefano; De Vita, Salvatore; Shoenfeld, Yehuda.

In: Journal of Autoimmunity, Vol. 32, No. 3-4, 05.2009, p. 261-266.

Research output: Contribution to journalArticle

Agmon-Levin, N, Ram, M, Barzilai, O, Porat-Katz, BS, Parikman, R, Selmi, C, Gershwin, ME, Anaya, JM, Youinou, P, Bizzaro, N, Tincani, A, Tzioufas, AG, Cervera, R, Stojanovich, L, Martin, J, Gonzalez-Gay, MA, Valentini, G, Blank, M, SanMarco, M, Rozman, B, Bombardieri, S, De Vita, S & Shoenfeld, Y 2009, 'Prevalence of hepatitis C serum antibody in autoimmune diseases', Journal of Autoimmunity, vol. 32, no. 3-4, pp. 261-266. https://doi.org/10.1016/j.jaut.2009.02.017
Agmon-Levin N, Ram M, Barzilai O, Porat-Katz BS, Parikman R, Selmi C et al. Prevalence of hepatitis C serum antibody in autoimmune diseases. Journal of Autoimmunity. 2009 May;32(3-4):261-266. https://doi.org/10.1016/j.jaut.2009.02.017
Agmon-Levin, Nancy ; Ram, Maya ; Barzilai, Ori ; Porat-Katz, Bat sheva ; Parikman, Ronit ; Selmi, Carlo ; Gershwin, M. Eric ; Anaya, Juan Manuel ; Youinou, Pierre ; Bizzaro, Nicola ; Tincani, Angela ; Tzioufas, Athanasios G. ; Cervera, Ricard ; Stojanovich, Ljudmila ; Martin, Javier ; Gonzalez-Gay, Miguel Angel ; Valentini, Gabriele ; Blank, Miri ; SanMarco, Marielle ; Rozman, Blaž ; Bombardieri, Stefano ; De Vita, Salvatore ; Shoenfeld, Yehuda. / Prevalence of hepatitis C serum antibody in autoimmune diseases. In: Journal of Autoimmunity. 2009 ; Vol. 32, No. 3-4. pp. 261-266.
@article{cc70f4af6c10420abc088ab9cc11c256,
title = "Prevalence of hepatitis C serum antibody in autoimmune diseases",
abstract = "Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from the same countries and with similar age and sex distribution. All sera were tested for the presence of serum anti-hepatitis C virus (HCV) antibodies as well as antibodies directed at other infectious agents and autoantibodies. Results: Anti-HCV antibody was detected in 115/1322 (8.7{\%}) of patients with AID and 0.4{\%} of matched healthy controls (P < 0.0001). The prevalence of anti-HCV antibody was significantly higher in 7/18 different AID (i.e. cryoglobulinemia, mixed cryoglobulinemia pemphigus vulgaris, vasculitis, secondary anti-phospholipid syndrome, Hashimoto's thyroiditis, and inflammatory bowel disease) compared to controls. Patients with AID and serum anti-HCV positivity had an increased prevalence of antibodies against hepatitis B virus, Toxoplasma gondii and Cytomegalovirus as opposed to a lower frequency of serum autoantibodies. Conclusions: The enhanced prevalence of anti-HCV serum antibodies in AID may suggest a role for HCV in tolerance to breakdown, similarly to its established role in mixed cryoglobulinemia. This immune mediated effect does not rule out the role of other infectious agents.",
keywords = "Antiphospholipids syndrome, Autoantibodies, Autoimmune diseases, Cryoglobulinemia, Hepatitis-C, Inflammatory bowel diseases, Pemphigus vulgaris, Thyroid autoimmune diseases",
author = "Nancy Agmon-Levin and Maya Ram and Ori Barzilai and Porat-Katz, {Bat sheva} and Ronit Parikman and Carlo Selmi and Gershwin, {M. Eric} and Anaya, {Juan Manuel} and Pierre Youinou and Nicola Bizzaro and Angela Tincani and Tzioufas, {Athanasios G.} and Ricard Cervera and Ljudmila Stojanovich and Javier Martin and Gonzalez-Gay, {Miguel Angel} and Gabriele Valentini and Miri Blank and Marielle SanMarco and Blaž Rozman and Stefano Bombardieri and {De Vita}, Salvatore and Yehuda Shoenfeld",
year = "2009",
month = "5",
doi = "10.1016/j.jaut.2009.02.017",
language = "English (US)",
volume = "32",
pages = "261--266",
journal = "Journal of Autoimmunity",
issn = "0896-8411",
publisher = "Academic Press Inc.",
number = "3-4",

}

TY - JOUR

T1 - Prevalence of hepatitis C serum antibody in autoimmune diseases

AU - Agmon-Levin, Nancy

AU - Ram, Maya

AU - Barzilai, Ori

AU - Porat-Katz, Bat sheva

AU - Parikman, Ronit

AU - Selmi, Carlo

AU - Gershwin, M. Eric

AU - Anaya, Juan Manuel

AU - Youinou, Pierre

AU - Bizzaro, Nicola

AU - Tincani, Angela

AU - Tzioufas, Athanasios G.

AU - Cervera, Ricard

AU - Stojanovich, Ljudmila

AU - Martin, Javier

AU - Gonzalez-Gay, Miguel Angel

AU - Valentini, Gabriele

AU - Blank, Miri

AU - SanMarco, Marielle

AU - Rozman, Blaž

AU - Bombardieri, Stefano

AU - De Vita, Salvatore

AU - Shoenfeld, Yehuda

PY - 2009/5

Y1 - 2009/5

N2 - Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from the same countries and with similar age and sex distribution. All sera were tested for the presence of serum anti-hepatitis C virus (HCV) antibodies as well as antibodies directed at other infectious agents and autoantibodies. Results: Anti-HCV antibody was detected in 115/1322 (8.7%) of patients with AID and 0.4% of matched healthy controls (P < 0.0001). The prevalence of anti-HCV antibody was significantly higher in 7/18 different AID (i.e. cryoglobulinemia, mixed cryoglobulinemia pemphigus vulgaris, vasculitis, secondary anti-phospholipid syndrome, Hashimoto's thyroiditis, and inflammatory bowel disease) compared to controls. Patients with AID and serum anti-HCV positivity had an increased prevalence of antibodies against hepatitis B virus, Toxoplasma gondii and Cytomegalovirus as opposed to a lower frequency of serum autoantibodies. Conclusions: The enhanced prevalence of anti-HCV serum antibodies in AID may suggest a role for HCV in tolerance to breakdown, similarly to its established role in mixed cryoglobulinemia. This immune mediated effect does not rule out the role of other infectious agents.

AB - Objective: To evaluate the prevalence of serum antibodies against hepatitis C virus and other infectious agents in a large cohort of well-characterized patients with autoimmune diseases (AID). Methods: We utilized 1322 sera from patients with 18 different AID and 236 sera from healthy controls from the same countries and with similar age and sex distribution. All sera were tested for the presence of serum anti-hepatitis C virus (HCV) antibodies as well as antibodies directed at other infectious agents and autoantibodies. Results: Anti-HCV antibody was detected in 115/1322 (8.7%) of patients with AID and 0.4% of matched healthy controls (P < 0.0001). The prevalence of anti-HCV antibody was significantly higher in 7/18 different AID (i.e. cryoglobulinemia, mixed cryoglobulinemia pemphigus vulgaris, vasculitis, secondary anti-phospholipid syndrome, Hashimoto's thyroiditis, and inflammatory bowel disease) compared to controls. Patients with AID and serum anti-HCV positivity had an increased prevalence of antibodies against hepatitis B virus, Toxoplasma gondii and Cytomegalovirus as opposed to a lower frequency of serum autoantibodies. Conclusions: The enhanced prevalence of anti-HCV serum antibodies in AID may suggest a role for HCV in tolerance to breakdown, similarly to its established role in mixed cryoglobulinemia. This immune mediated effect does not rule out the role of other infectious agents.

KW - Antiphospholipids syndrome

KW - Autoantibodies

KW - Autoimmune diseases

KW - Cryoglobulinemia

KW - Hepatitis-C

KW - Inflammatory bowel diseases

KW - Pemphigus vulgaris

KW - Thyroid autoimmune diseases

UR - http://www.scopus.com/inward/record.url?scp=67349203916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349203916&partnerID=8YFLogxK

U2 - 10.1016/j.jaut.2009.02.017

DO - 10.1016/j.jaut.2009.02.017

M3 - Article

C2 - 19356903

AN - SCOPUS:67349203916

VL - 32

SP - 261

EP - 266

JO - Journal of Autoimmunity

JF - Journal of Autoimmunity

SN - 0896-8411

IS - 3-4

ER -